© 2018 Ortho-tag, Inc.

This information concerns a use that has not been approved or cleared by the Food and Drug Administration

Ortho-tag

Proprietary technologies and intellectual property that enable and enhance wireless, real-time communication though the human body; implanted sensor diagnostics; and in vivo data exchange/storage and drug administrative capabilities of smart medical implants

In-Body Communication

Provides a unique system utilizing a patented transcutaneous volume conduction to wirelessly communicate through the human body with implanted medical devices

Transcutaneous volume conduction communication has many advantages over traditional RFID, as well as enabling the highest level of data security

Provides the solution to powering implantable chips/tags and nanobiosensors without the use

of an internal battery

Provides the solution to overcoming signal interference with other metallic implants

Implantable Data 

Provides an in vivo system and method for communicating and storing data, information and images relating to a medical implant device and incorporated nanosensors

Provides real-time data access and secure exchange with implanted

(high-capacity) chips/tags

Enables identification of patient’s implanted device with unique identification (UDI) compliance

Customized platform can be applied to various medical implants and future applications - Orthopedic implants (hip/knee/spine, trauma) Cardiac, neurological, gastrointestinal, urological and other surgical implants

NanoBiosensor Technologies

Enables the ability to detect, through integrated, custom designed nanosensors, the presence of surgical and prosthetic joint infection – in real time

Provides early detection (and intervention) of a progressing infection that adds an additional layer of post-operative patient safety

Future nanotechnolgy is being developed to monitor tissue environment for detecting infection and disease, stimulation of bone healing, and

other therapeutic applications

In Vivo Drug Administration

State-of-the-art antimicrobial implant coating (provisional patent) against

drug resistant bacteria, which does

not further mutate bacteria - provides rest line of implant infection defense

Two-way communication provides chemical sensing capabilities for multiple modes of bone growth,

inflammation and infection sensing

Remote capability to implant, store,

and release (on demand) a wide-range of antibiotics